Moleculin Biotech, Inc. (MBRX) vs MetaVia Inc. (MTVA)
Moleculin Biotech, Inc. and MetaVia Inc. are both Biotechnology companies. Moleculin Biotech, Inc. and MetaVia Inc. are of similar size ($11.2M and $10.9M). MetaVia Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, MetaVia Inc. leads on 5 and Moleculin Biotech, Inc. on 4.
Valuation
Profitability
| Metric | MBRX | MTVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (1,471.05%) | (175.68%) | (57.72%) |
| Return on assets | (152.41%) | (91.06%) | (49.22%) |
| Return on invested capital | (417.27%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack